Answers are grounded in this paper and cite their sources.
The hypoxic characteristics of the tumor microenvironment and endogenous antioxidant defenses compromise the efficacy of oxygen-consuming oxidative therapy, positioning oxygen-free reductive stress as a new paradigm in tumor treatment. Nevertheless, the immunosuppressive characteristics of hypoxia and reductive stress pose significant challenges for advancing reductive stress-induced immunotherapy. Here, we constructed a hydrogen radical (H•) generator synergistically activated by near-infrared light and thiols, and first elucidated that photocatalytic H•-mediated reductive stress can elicit a robust antitumor immune response via the H•-featured mechanism. Nanoplatform HA@UFTL was engineered using lactate oxidase as an ideal H• partner, with the synergistic contribution enabling cross-amplified antitumor immunotherapy. The H•-participating spatiotemporal sequential strategy highlights a triple spatiotemporal sequential cascade, including dual sequential hypoxia exacerbation, sequential oxidative-reductive stress, and sequential organelle damage. By aggravating rather than alleviating hypoxia, HA@UFTL overcomes immunosuppression induced by hypoxia and reductive stress with H• as a universal building block, providing new insights for hypoxia-based immunotherapy.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: